Related Experiment Video

Updated: Apr 5, 2026

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

9.1K

Phosphatidylinositolphosphate phosphatase activities and cancer

Simon A Rudge1, Michael J O Wakelam1

  • 1Signalling Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom Simon.rudge@babraham.ac.uk Michael.wakelam@babraham.ac.uk.

Journal of Lipid Research
|August 26, 2015
PubMed

Insights

Phosphoinositide 3-kinase (PI3K) pathways regulate cell signaling. Dysregulation, particularly by phosphoinositide phosphatases, is linked to cancer development and progression.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Phosphoinositide 3-kinase (PI3K) pathways are crucial signaling cascades.
  • These pathways are activated by various extracellular signals like hormones and growth factors.
  • Overactivation of PI3K signaling is frequently observed in malignancies.

Purpose of the Study:

  • To review the human phosphoinositide phosphatase families.
  • To elucidate the role of these phosphatases in regulating phosphoinositide levels.
  • To understand how phosphoinositide dysregulation contributes to cancer.

Main Methods:

  • Literature review of phosphoinositide phosphatase families.
  • Analysis of signaling pathway regulation.
  • Discussion of phosphoinositide metabolism in cancer.

Main Results:

  • Identified key phosphoinositide phosphatase families in humans.
  • Detailed the enzymatic activities of these phosphatases.
  • Linked phosphatase activity to phosphoinositide levels and malignancy.

Conclusions:

  • Phosphoinositide phosphatases are critical regulators of PI3K signaling.
  • Imbalances in phosphatase activity can lead to oncogenic signaling.
  • Targeting these phosphatases may offer therapeutic strategies for cancer.
Keywords:
cancerlipid kinasesphosphatases/lipidphosphoinositide 3-kinasephosphoinositides

More Related Videos

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry09:22

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry

Published on: August 13, 2021

2.9K
Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation10:52

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation

Published on: January 6, 2016

10.9K

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
16.0K